1) Scott IU, Siatkowski RM. Thyroid eye disease. Semin Ophthalmol 1999;14:52-61.
3) Kotwal A, Stan M. Thyrotropin receptor antibodies-an overview. Ophthalmic Plast Reconstr Surg 2018;34:S20-7.
5) Kurioka Y, Inaba M, Kawagishi T, et al. Increased retinal blood flow in patients with Graves' disease: influence of thyroid function and ophthalmopathy. Eur J Endocrinol 2001;144:99-107.
6) Li H, Liu Y, Li D, Zhang Y. Value of measurements of blood flow velocity in central retinal artery in thyroid-associated ophthalmopathy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2004;26:460-2.
7) Alimgil ML, Benian O, Esgin H, Erda S. Ocular pulse amplitude in patients with Graves' disease: a preliminary study. Acta Ophthalmol Scand 1999;77:694-6.
8) Alm A, Bill A. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp Eye Res 1973;15:15-29.
9) Balaratnasingam C, Inoue M, Ahn S, et al. Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion. Ophthalmology 2016;123:2352-67.
10) Biesemeier A, Taubitz T, Julien S, et al. Choriocapillaris breakdown precedes retinal degeneration in age-related macular degeneration. Neurobiol Aging 2014;35:2562-73.
14) Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009;147:811-5.
15) Ardeljan D, Chan CC. Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res 2013;37:68-89.
16) Woo KI, Kim YD, Lee SY. The clinical characteristics of thyroid orbitopathy in thyroid dysfunction patients in Korea. J Korean Ophthalmol Soc 2008;49:1387-96.
17) Park KA, Oh SY. Choroidal thickness in healthy children. Retina 2013;33:1971-6.
18) Broadhead GK, Hong T, McCluskey P, et al. Choroidal thickness and microperimetry sensitivity in age-related macular degeneration. Ophthalmic Res 2017;58:27-34.
19) Lavia C, Bonnin S, Maule M, et al. Vessel density of superficial, intermediate, and deep capillary plexuses using optical coherence tomography angiography. Retina 2019;39:247-58.
23) Khong JJ, Goldstein RF, Sanders KM, et al. Serum selenium status in Graves’ disease with and without orbitopathy: a case-control study. Clin Endocrinol (Oxf) 2014;80:905-10.
24) Nag TC, Wadhwa S. Vascular changes of the retina and choroid in systemic lupus erythematosus: pathology and pathogenesis. Curr Neurovasc Res 2006;3:159-68.
25) Nielsen CH, Brix TH, Leslie RG, Hegedüs L. A role for autoantibodies in enhancement of pro-inflammatory cytokine responses to a self-antigen, thyroid peroxidase. Clin Immunol 2009;133:218-27.
26) Chu CH, Lee JK, Keng HM, et al. Hyperthyroidism is associated with higher plasma endothelin-1 concentrations. Exp Biol Med (Maywood) 2006;231:1040-3.
27) Wu Y, Tu Y, Bao L, et al. Reduced retinal microvascular density related to activity status and serum antibodies in patients with Graves’ ophthalmopathy. Curr Eye Res 2020;45:576-84.
28) Ye L, Zhou SS, Yang WL, et al. Retinal microvasculature alteration in active thyroid-associated ophthalmopathy. Endoc Pract 2018;24:658-67.
30) Jorge R, Scott IU, Akaishi PM, et al. Resolution of choroidal folds and improvement in visual acuity after orbital decompression for graves orbitopathy. Retina 2003;23:563-5.
31) Gul A, Basural E, Ozturk HE. Comparison of choroidal thickness in patients with active and stable thyroid eye disease. Arq Bras Oftalmol 2019;82:124-8.
34) Ersan I, Oltulu R, Altunkaya O, et al. Relationship of inferior oblique overaction to macular and subfoveal choroidal thickness. J AAPOS 2015;19:21-3.